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A B S T R A C T
Most studies about serpin peptidase inhibitor, clade A member 3 (SERPINA3) has been limited to its inhibitory
functions and mechanisms. Herein, we report a novel role of SERPINA3 in transcriptional regulation of HCC
progression-related genes. Among 19 selected genes through HCC cell isolation system based on telomere length,
microarray analyses, and cell-based studies, SERPINA3 was the strongest determinant of increases in telomere
length, HCC cell proliferation, survival, migration, and invasion. We also found that SERPINA3 strongly inter-
acted with heterogeneous nuclear ribonucleoprotein K (HNRNP-K) under H2O2 exposure, and the oxidation-
elicited SERPINA3-HNRNP-K complex enhanced the promoter activities and transcript levels of a telomere-
relating gene (POT1) and HCC-promoting genes (UHRF1 and HIST2H2BE). Intriguingly, the inhibition of
SERPINA3 oxidation rendered the transcriptional activity of the SERPINA3-HNRNP-K complex suppressed.
Moreover, the co-immunoprecipitated HNRNP-K with SERPINA3 quantitatively correlated with not only the
level of SERPINA3 oxidation but also the level of POT1, UHRF1, and HIST2H2BE transcripts and telomere length
in HCC tissues. Therefore, the upregulated transcriptional activity of HNRNP-K mediated by SERPINA3 promotes
HCC cell survival and proliferation and could be an indicator of poor prognosis for HCC patients.
1. Introduction
Liver hepatocellular carcinoma (HCC) is the second leading cause of
cancer-related death worldwide, with a mortality rate exceeding 37% in
Asia for patients ≥50 years of age and approximate 5-year survival
rates of 15% in the United States, and 12% in Europe [1,2]. The in-
cidence and mortality rates of HCC are expected to increase steadily
[1,2]. Despite the increasing number of treatment options against ad-
vanced HCC (GII and GIII HCC), the selection of a suitable treatment
strategy can be difficult [1,2]. This is not only because HCC is a very
heterogeneous disease induced by multiple underlying etiologies, mo-
lecules, and signaling pathways, but also the drug-mediated hepato-
toxicity can occur during treatment [1,2]. Major risk factors for HCC
such as the chronic viral infections (hepatitis B or C virus), alcoholic
hepatitis, and non-alcoholic fatty liver disease increase the level of re-
active oxygen species (ROS) [3,4]. The ROS levels are strongly corre-
lated with the progression of human HCC from early-to advanced-grade
[5,6]. HCC cell lines under the elevated ROS environment also show
similar malignant phenotypes with the advanced HCC tissues [5–7].
These phenotypes encompass the decreased level of antioxidant en-
zymes [5,7], the increased epithelial-to-mesenchymal transition (EMT)
[5], the increased activity of cell invasion and migration [5–7], the
increased expression of telomerase reverse transcriptase (TERT), the
enhanced telomerase activity, and the elongated telomere length [6].
It has been known that the heterogeneous nuclear ribonucleopro-
tein-K (hnRNP-K) was upregulated in human HCC tumor tissues, com-
pared to the corresponding non-tumorous tissues [8]. Similarly, the
upregulated hnRNP-K expression has been correlated with poor clinical
outcomes and HCC malignancy [8]. The hnRNPs comprise a large fa-
mily of proteins that play important roles in telomere biogenesis, DNA
repair, and the regulation of expression at both the transcriptional and
translational levels [9,10]. The hnRNP-K, which is one of the most
extensively studied hnRNP family members, recognizes the C-rich
binding motif in gene regulatory and telomeric DNA [8–10]. It has been
suggested that the binding of hnRNP-K to the specific C-rich motifs
could be essential in diverse signal transduction pathways, including
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growth regulation and cellular transformation [8,9], but the mod-
ulatory mechanisms regarding the hnRNP-K transcriptional activity in
HCC still remain unclear.
Recently we reported that the serpin peptidase inhibitor, clade A
member 3 (SERPINA3) was a transcriptional activator of PI3Kδ ex-
pression in HCC progression [11]. ROS induced oxidative modification
of specific residues in SERPINA3, thereby leading to PI3Kδ signaling
activation and HCC proliferation [11]. In this paper, we provide the
mechanism for the SERPINA3-mediated transcriptional expression of
genes responsible for HCC progression. SERPINA3 modulates hnRNP-K
transcriptional activity through interaction with the HNRNP-K-protein-
interactive (KI) domain of hnRNP-K in human HCC cell lines. For the
interaction of SERPINA3 with hnRNP-K through KI domain, the ROS-
dependent oxidation of SERPINA3 protein was found to be the pre-
requisite step. Moreover, the strong interaction of SERPINA3 with
HNRNP-K promoted HCC cell survival and proliferation via regulating
the gene transcriptions involved in telomere-maintenance and HCC
malignancy. Thus, blockade of the association of SERPINA3 with
HNRNP-K protein could be valuably used for HCC therapy.
2. Materials and methods
All detail experimental procedures have been described in the
supplementary information. Please see details in SI Appendix.
3. Results
3.1. Identification of a novel role of SERPINA3 as a molecular linker
between telomere maintenance factors and HCC tumorigenic factors
We previously documented that H2O2 treatment induced a telomere
elongation and cell invasion [5,6,12] in HCC cells. In this study, to
further examine the molecular linkage between telomere maintenance
and cell invasion, we isolated cells with H2O2-mediated long telomeres
(cells with top 6% of telomere intensity) and short telomeres (cells with
bottom 66% of telomere intensity), respectively (Fig. 1A). HCC cells
with long telomeres showed a higher invasion ability, as well as better
in vivo tumor growth compared to the short telomere-containing cells
(Fig. 1B and C). While the BIBR1532, a telomerase inhibitor, alone was
not enough to shorten telomeres in HCC cell lines even after two-weeks
(SI Appendix, Fig. S1), co-treatment with BIBR1532 and H2O2 fa-
cilitated the telomere shortening (SI Appendix, Fig. S1). This is con-
sistent with the previous reports describing severe telomeric damage
caused by H2O2 in HCC cells under telomerase inhibition [6]. After the
induction of telomere shortening, HCC cells with long telomeres also
exhibited decreased telomere length, cell migration, invasion, and in
vivo tumor growth (Fig. 1B and C). Taken together, these results suggest
that the telomere length positively associates with the HCC cell mi-
gration, invasion, and tumor growth, and the telomere machinery may
be linked with the HCC-progression factors.
To identify the regulatory factor(s) which links the telomere main-
tenance factors with HCC-progression factors, we analyzed the micro-
array data of HCC cells with long and short telomeres (GEO accession
number GSE114004), and found that UHRF1, HIST2H2BE, ARL14,
PTGS2, MYLIP, HINT3, PTGER4, UGCG, ZNF121, HSD3B1, TMEM27,
and SULT2A1 were upregulated, while SERPINA3, MT1X, SCL6A14,
AHSG, ITIH2, ORM1, and ORM2 were downregulated in long telomere-
containing HCC cells (Fig. 1D). To determine the subcellular localiza-
tion of the candidate proteins, the candidates were tagged with EGFP at
the individual N-terminus and expressed in Huh7 cells (Fig. 1D and E; SI
Appendix, Fig. S2). Among the 19 candidates, 10 genes (SERPINA3,
UHRF1, HIST2H2BE, ARL14, PTGS2, MT1X, SCL6A14, MYLIP, AHSG,
and HINT3) were frequently distributed in telomeres after H2O2 treat-
ment (Fig. 1E; SI Appendix, Fig. S2). Approximately 90–95% of HCC
tumor cells showed telomerase-dependent telomere maintenance
[13–15]. Telomere maintenance is required for evading the cellular
crisis induced by the shortened telomeres during liver cirrhosis [3,4,6].
Thus, we hypothesized that telomere maintenance might be essential
for HCC progression and the genes, which represent an altered fre-
quency of telomere localization under H2O2 treatment, could affect
telomere maintenance-mediated HCC tumor progression.
We next dissected the roles of 10 selected genes based on the H2O2
treatment dependent changes in the telomere localization frequency
using Ingenuity Pathway Analysis (IPA) (SI Appendix, Fig. S3A). The
IPA of differentially expressed genes including the 10 selected genes,
predicted the prominent function of tumor progression signaling net-
works (SI Appendix, Fig. S3A). We next quantified telomere lengths, the
transcript levels of telomerase subunits, and invasion-associated genes
in HCC cells during gene overexpression (Fig. 1F; SI Appendix, Figs. S3B
and S3C). In addition, we measured cell growth rates, cell migration
and invasion abilities, and the high-dose chemical-mediated mortality
rates in the HCC cells following gene overexpression (Fig. 1F; SI Ap-
pendix, Figs. S3B and S3C). Overall, we concluded that SERPINA3 was
the most determining gene candidate responsible for telomere main-
tenance, HCC cell proliferation, survival, migration, and invasion
(Fig. 1F; SI Appendix, Figs. S3B and S3C).
3.2. Involvement of SERPINA3 in HNRNP-K’s transcriptional activity
SERPINA3 activity to promote both telomere elongation and HCC
progression was upregulated under H2O2 exposure (Fig. 1). To disclose
the underlying mechanism of SERPINA3-mediated telomere main-
tenance and HCC malignancy, we aimed to identify interacting partners
with SERPINA3 under H2O2 treatment in HCC cells. Co-im-
munoprecipitation (co-IP) and LC-MS/MS analyses showed 21 protein
candidates for SERPINA3 interactome (Fig. 2A; SI Appendix, Fig. S4).
Via label-free quantification analysis of co-IP LC-MS/MS data against
those from the mock- and H2O2-treated Huh7 cells, we further identi-
fied HNRNP-K as an H2O2-sensitive binding partner of SERPINA3
(Fig. 2A and B; SI Appendix, Fig. S4). The KI domain corresponding to
amino acids 210–340 in HNRNP-K, was the binding part to SERPINA3
(Fig. 2B).
We previously reported the increased oxidation levels of methionine
residues including M137, M141, M284, and M290 in SERPINA3 in-
duced by H2O2 treatment and the lack of oxidation levels induced by
mutating the methionine to leucine [11]. H2O2 increased the nuclear
levels of both SERPINA3 and HNRNP-K proteins (Fig. 2C left) and in-
duced the strong association of SERPINA3 with HNRNP-K in HCC cells
(Fig. 2C right). In particular, the SERPINA3 variant exhibiting low
oxidation levels markedly failed to coimmunoprecipitate with HNRNP-
K (Fig. 3A). To determine whether the oxidation-defective SERPINA3
influenced HNRNP-K transcription activity, we compared expression
levels of protection of telomeres 1 (POT1), which is the target gene of
the transcription factor, HNRNP-K [16], between HCC cells, following
overexpression of the SERPINA3 WT and SERPINA3 oxidation-defective
variant (Fig. 3B left). The promoter activity and transcription level of
POT1 was reduced by the SERPINA3 oxidation variant (Fig. 3B left).
The promoter activity and transcription level of PI3Kδ, which was
changed by SERPINA3 expression in regard to transcription level [11],
was also decreased by the oxidation variant (Fig. 3B middle left). Based
on data showing that SERPINA3 only influenced the expressions of
UHRF1 and HIST2H2BE (SI Appendix, Figs. S5 and S6) among the 19
genes selected in Fig. 1 and SI Appendix, Figs. S2–S3, we also tested the
effect of the SERPINA3 oxidation defect on UHRF1 and HIST2H2BE
expressions. SERPINA3 oxidation variant decreased promoter activity
and transcription level of UHRF1 and HIST2H2BE (Fig. 3B middle right
and right). Accordingly, oxidation of SERPINA3 is responsible for the
POT1, UHRF1, HIST2H2BE, and PI3Kδ transcription levels in HCC cells.
We next determined that the transcriptional repression effect by the
SERPINA3 oxidation defect involved a blockade of HNRNP-K activity.
To examine the effect of this defect by the removal of endogenous ac-
tivity, we established HCC cell lines stably expressing the SERPINA3
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oxidation-defective variant plasmid, which is not degraded by
SERPINA3 siRNA, and then administered SERPINA3 siRNA to the stable
cell lines. The SERPINA3 deficiency using SERPINA3 siRNA remarkably
decreased POT1, UHRF1, HIST2H2BE, and PI3Kδ transcription levels in
the HCC cell lines stably expressing SERPINA3 oxidation-defective
mutant (Fig. 3C). Similarly, siRNA-mediated HNRNP-K silencing
Fig. 1. SERPINA3 induces telomere elongation, cell migration and invasion, cell proliferation, and resistance to cell toxicity in HCC cells. (A) Strategy for sorting
Huh7 HCC cells according to telomeric intensity. The telomere marker TPP1 and nuclei are evident as green and blue fluorescence, respectively. Scale bars, 10 μm.
(B–C) Migration (B left) and invasion assay (B right) and tumor growth of mice (C) of Huh7-cells with short telomeres or long telomeres with or without the induction
of telomere shortening by treatment with both 300 μMH2O2 and 15 μM of the telomerase inhibitor BIBR 1532. (D) Microarray analysis of gene expression of short
telomere-exhibiting cell fractions and long telomere-exhibiting cell fractions in H2O2-treated Huh7 HCC cells. (E) Fluorescence images of SERPINA3 protein loca-
lization in mock- and H2O2-treated Huh7 cells (top) and percentage of co-localization of SERPINA3 with telomeres per cell (bottom). Scale bars, 5 μm. (F) Functional
profiling of candidate genes by analyses of telomere length (top left), cell migration (top middle), invasion (top right), cell proliferation (bottom left), and cell
survival in Huh7 cells treated with the cell toxicant (1mMH2O2) (bottom right). HCC, hepatocellular carcinoma; H2O2, hydrogen peroxide; EGFP, enhanced green
fluorescent protein; T/S, the ratio of telomere repeat copy number (T) to single copy number (S); E.V, empty vector; POC, percent of control; Mean ± s.e.m. (n=3),
except for Fig. 1C (Mean ± s.d., n=6). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, Student's t-test. Sterile distilled water (pH 7.0) was used as the negative control
(mock treatment). . (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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significantly diminished transcription levels of the above-mentioned
genes in the stable cell lines and human primary HCC cells (Figs. 3C and
SI Appendix, Fig. S7A). This indicates that SERPINA3 functions in
oxidized form to enable the transcriptional activity of HNRNP-K.
Overall, these results suggested that decrease in oxidatively-modified
SERPINA3 weakens the interaction between SERPINA3 and HNRNP-K
and results in transcriptional downregulation of genes that are influ-
enced by the SERPINA3-HNRNP-K complex.
3.3. Action of SERPINA3-HNRNP-K complex in transcriptional activation
of POT1, UHRF1, and HIST2H2BE genes
To address the mechanism of action of the oxidized-SERPINA3 in
regulation of POT1, UHRF1, and HIST2H2BE transcription, we per-
formed the ChIP assay using HCC cells stably expressing SERPINA3 WT
or the oxidation-defective variant. We found that the impaired oxida-
tion of the SERPINA3 protein abolished the binding of SERPINA3 to the
regulatory DNA in the POT1, UHRF1, and HIST2H2BE genes (Fig. 4A).
We next determined whether SERPINA3 and HNRNP-K co-occupy the
Fig. 2. SERPINA3 interacts with HNRNP-K and H2O2 induces increased association between SERPINA3 and HNRNP-K. (A) Experimental overview of the im-
munoprecipitation and LC-MS/MS analyses for the identification of interacting proteins with SERPINA3 in Huh7 HCC cells. (B) Diagrams of the FLAG-tagged HNRNP-
K structure and its deletion mutants and EGFP-tagged SERPINA3 structure (left) and GFP immunoprecipitation followed by immunoblotting analyses using antibodies
against FLAG in Huh7 cells expressing full-length FLAG-tagged HNRNP-K or its deletion mutants and full-length EGFP-tagged SERPINA3 (right). (C)
Immunofluorescence of endogenous SERPINA3 and HNRNP-K (left) and immunoprecipitation with anti-SERPINA3 antibody followed by immunoblot analyses with
anti-HNRNP-K antibody (right) on Huh7-cells with mock or H2O2 treatment. Sterile distilled water (pH 7.0) was used as the negative control (mock treatment). EGFP,
enhanced green fluorescent protein; FL, full-length; DL, deletion mutant; KH, HNRNP-K-homology; KI, HNRNP-K-interactive; SERPIN, serine protease inhibitors; RCL,
Reactive Center Loop; AAs, amino acids; IP, immunoprecipitation; IB, immunoblot; IgG, immunoglobulin G. . (For interpretation of the references to colour in this
figure legend, the reader is referred to the Web version of this article.)
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same regions as the regulatory DNA in POT1, UHRF1, and HIST2H2BE
genes, and found that SERPINA3 formed a complex with HNRNP-K on
the regulatory DNA in these genes (Fig. 4B). While H2O2 induced a
marked increase in the binding of HNRNP-K coimmunoprecipitated
with SERPINA3 on these regulatory DNA, the ROS scavenger reagent N-
acetylcysteine (NAC) abolished the H2O2-mediated binding of the
SERPINA3-HNRNP-K complex (Fig. 4B). These results suggest that
SERPINA3 that was oxidatively modified by H2O2 treatment increased
the binding of the HNRNP-K-SERPINA3 complex in regulatory DNAs in
POT1, UHRF1, and HIST2H2BE genes.
We next determined the effect of the SERPINA3 oxidation defect on
the HNRNP-K binding to the regulatory DNA in POT1, UHRF1, and
HIST2H2BE genes. ChIP data revealed that SERPINA3 oxidation im-
pairment induced a sharp reduction in HNRNP-K binding to these
regulatory DNA (Fig. 4C). This data indicated that the impaired oxi-
dation on SERPINA3 limits the function of HNRNP-K as a transcrip-
tional regulator. Further, we showed that the oxidation-defective
SERPINA3 mutant displayed decreased telomere lengths, invasion
ability, and cell viability as well as increased Caspase-3/7 activity
(Fig. 4D). This is consistent with the observation of siRNA-mediated
Fig. 3. Lack of interaction between SERPINA3 and HNRNP-K reduces promoter activities and mRNA expression levels of POT1 PI3Kδ, UHRF1, and HIST2H2BE. (A) A
view of the location of the oxidation modified residues M219 and M290 on SERPINA3 protein (left) and GFP immunoprecipitation followed by immunoblotting
analyses using antibodies against FLAG in Huh7 cells expressing FLAG-tagged HNRNP-K and EGFP-tagged SERPINA3 WT, M219L, or M290L (right). (B) Transcription
levels (top) and promoter activities (bottom) of POT1, PI3Kδ, UHRF1, and HIST2H2BE in HCC cells, following overexpression of EGFP E.V, SERPINA3 WT, SERPINA3
M219L, or SERPINA3 M290L plasmid. (C) Transcription levels of POT1, PI3Kδ, UHRF1, and HIST2H2BE in HCC cells stably expressing the SERPINA3 M290L plasmid,
which is not degraded by SERPINA3 siRNA, followed by administration of siControl (siCon), siSERPINA3, and siHNRNP-K. EGFP, enhanced green fluorescent protein;
IP, immunoprecipitation; IgG, immunoglobulin G; WT, wild-type; E.V, empty vector; siCon, non-targeting siRNA; siRNA, short-interfering RNA; Mean ± s.e.m.
(n=3). ∗∗p < 0.01, Student's t-test. NS denotes non-significance. . (For interpretation of the references to colour in this figure legend, the reader is referred to the
Web version of this article.)
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HNRNP-K silencing in human primary HCC cells (SI Appendix, Fig.
S7B). Collectively, these results suggest that oxidatively-modified
SERPINA3 interacts with HNRNP-K, which results in the up-regulation
of POT1, UHRF1, and HIST2H2BE promoter activities and their tran-
scription, thereby promoting HCC cell telomere elongation, invasion,
proliferation, and survival.
3.4. SERPINA3-HNRNP-K complex as the target in the treatment of liver
tumor
The SERPINA3 oxidation-defective mutation interfered with
HNRNP-K binding to SERPINA3 and then inhibited HNRNP-K tran-
scriptional activity (Figs. 3 and 4). We administered subcutaneous
Fig. 4. Oxidatively-modified SERPINA3 promotes transcriptional activity of HNRNP-K through the increasing interaction between SERPINA3 and HNRNP-K (A)
Enrichment of EGFP-tagged SERPINA3 at the POT1 (left), UHRF1 (middle), and HIST2H2BE (right) gene regulatory DNAs in Huh7 cells expressing stably EGFP-tagged
SERPINA3 WT or SERPINA3 M290L. (B) Enrichment of SERPINA3 using anti-SERPINA3 antibody after the first ChIP assay using anti-HNRNP-K antibody at the POT1
(left), UHRF1 (middle), and HIST2H2BE (right) gene regulatory DNAs in Huh7 cells with and without H2O2 treatment. Sterile distilled water (pH 7.0) was used as the
negative control (mock treatment). (C) Enrichment of HNRNP-K at the POT1 (left), UHRF1 (middle), and HIST2H2BE (right) gene regulatory DNA in Huh7 cells stably
expressing the SERPINA3 M290L plasmid not degraded by siSERPINA3 followed by administration of siControl (siCon), siSERPINA3, and siHNRNP-K. Gel images
show the amount of HNRNP-K in the indicated gene regulatory DNA. (D) Telomere length, invasion activity, caspase-3/7 activity, and cell viability of Huh7 cells
stably expressing the SERPINA3 M290L plasmid not degraded by siSERPINA3 followed by administration of siControl (siCon), siSERPINA3, and siHNRNP-K. siCon,
non-targeting siRNA; siRNA, short-interfering RNA; WT, wild-type; ChIP, chromatin-immunoprecipitation; IgG, immunoglobulin G; H2O2, hydrogen peroxide; NAC,
N-acetylcysteine; Mean ± s.e.m. (n= 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, Student's t-test. NS denotes non-significance.
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(Fig. 5A) and intrahepatic injections (Fig. 5B) of Huh7 cells stably ex-
pressing SERPINA3 oxidation-defect to immunodeficient mice and
tested whether the SERPINA3 oxidation-impairment inhibited tumor
growth in vivo. Notably, we showed that SERPINA3 oxidation-defect
decreased growth of subcutaneous (Fig. 5A) and liver tumors (Fig. 5B
top). Moreover, the SERPINA3 oxidation-defect reduced the number of
liver nodules, the mRNA levels of UHRF1, HIST2H2BE, and POT1, as
well as telomere lengths (Fig. 5B bottom). Similar phenotypes were
observed in the case of HNRNP-K knock-down through siRNA admin-
istration (Fig. 5A and B); supporting data showed that the SERPINA3-
HNRNP-K complex acts as a transcriptional regulator (Figs. 3 and 4).
Together, our results indicate that oxidative-modification of SERPINA3
is critical for the functioning of the SERPINA3-HNRNP-K complex as a
transcriptional regulator in liver tumor progression. Furthermore, the
increased association of SERPINA3 with HNRNP-K could promote ma-
lignant liver progression by modulating the expression of genes in-
volved in HCC malignancy and telomere maintenance (Fig. 5C).
In human GIII HCC tissues, protein expression levels of SERPINA3,
HNRNP-K, UHRF1, HIST2H2BE, and POT1 were higher than those in
paired non-tumor tissues (Fig. 6A). SERPINA3 and HNRNP-K proteins
were observed to be more distributed in the nuclei of GIII HCC tissues
(Fig. 6A), supporting the transcriptional regulator activity of the SER-
PINA3-HNRNP-K complex (Figs. 3–5). We next analyzed the correlation
between the levels of the oxidized-SERPINA3 protein and the amount of
coimmunoprecipitated HNRNP-K with SERPINA3 in GII and GIII HCC
tissues (Fig. 6B and C). Linear regression analysis revealed a significant
positive correlation between the oxidized-SERPINA3 levels and the
SERPINA3-HNRNP-K complex levels (Pearson correlation coefficient:
R= 0.8457; 95% confidence interval (CI)= 0.7864 to 0.8805;
p < 0.0001, Fig. 6C). The high amount of coimmunoprecipitated
HNRNP-K with SERPINA3 was significantly associated with the high
mRNA levels of UHRF1, HIST2H2BE, POT1, and longer telomeres
(Fig. 6D). Moreover, HCC patients with a high level of the SERPINA3-
HNRNP-K complex showed significantly frequent HCC recurrence
compared to those with low level of the complex (Hazard
ratio= 10.36, 95% CI=3.289 to 32.64, p < 0.0001; Fig. 6E). This
result suggests that the strong interaction between SERPINA3 and
HNRNP-K is a poor prognostic indicator of HCC. Next, we checked
whether the upregulation of genes activated by recruitment of HNRNP-
K to the gene loci, of which SERPINA3 binding to HNRNP-K can in-
crease its efficiency, is related to HCC patient's survival using The
Cancer Genome Atlas (TCGA) data. In agreement to our results, patients
with high UHRF1 expression showed poor survival (Fig. S8).
4. Discussion
Oxidative modification induced by ROS alters the stability and
function of proteins [17,18]. ROS triggers several signal transduction
pathways through the oxidation modification of protein kinases and
tyrosine phosphatases, including protein kinase C and phosphatase and
tensin homolog deleted on chromosome 10 (PTEN) in tumorigenesis
[19–21]. ROS also incrementally affects nuclear localization and the
affinity of regulatory DNA-interaction of transcription factors, such as
nuclear factor kappa B, p53, activating protein-1, and protein-disulfide
Fig. 5. The blockade of SERPINA3 binding to HNRNP-K inhibits murine tumor growth in vivo (A) Subcutaneous tumor volumes from mice that were subcutaneously
injected with Huh7 cells stably expressing the SERPINA3 oxidation-defect plasmid not degraded by siSERPINA3 followed by intra-tumoral injection of siSERPINA3
and siHNRNP-K (n=5). Student's t-test; Mean ± s.e.m. (B) Liver tumor growth inhibition in mice after intrahepatic injection of Huh7 cells stably expressing the
SERPINA3 oxidation-defect plasmid not degraded by siSERPINA3 followed by tail injection of siSERPINA3 and siHNRNP-K (n=5). Photographs of liver tumors (top)
and median number of tumor nodules (> 4mm), mRNA levels of UHRF1, HIST2H2BE, and POT1, and telomere fluorescence intensity (bottom). Horizontal bars
indicate median values. ∗∗p < 0.01, Mann–Whitney U test. (C) Molecular model illustrating action of oxidized-SERPINA3 complexed with HNRNP-K protein as a
transcriptional activator for HCC cell survival and proliferation. siCon, non-targeting siRNA; siRNA, short-interfering RNA; ROS,reactive oxygen species; KI, HNRNP-
K-interactive; HCC, hepatocellular carcinoma.
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Fig. 6. High-amount of coimmunoprecipitated HNRNP-K with SERPINA3 is associated with high levels of UHRF1, HIST2H2BE, and POT1 expressions as well as with
high HCC recurrence in human HCC tissues. (A) Representative immunohistochemical staining of SERPINA3, HNRNP-K, UHRF1, HIST2H2BE, and POT1 in GIII HCC
tumor samples and non-tumor samples. (B, C) Immunoprecipitation (IP) using anti-SERPINA3 antibodies followed by immunoblotting analyses using antibodies
against HNRNP-K in GII and GIII HCC tissue lysates (B), and correlation analysis between the oxidized-SERPINA3 and the amount of coimmunoprecipitated HNRNP-
K with SERPINA3 determined by linear regression (C). n= 48 (D, E) Median mRNA levels of UHRF1, HIST2H2BE, and POT1, and median telomere length (D) and
recurrence-free survival rates (E) in GII and GIII HCC tissues with low- and high-amount of coimmunoprecipitated HNRNP-K with SERPINA3 (n= 47). Horizontal
bars indicate median values. IP, immunoprecipitation; IB, immunoblot; GII, Grade-II; GIII, Grade-III; R, Pearson correlation coefficient; HCC, hepatocellular carci-
noma.
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isomerase-associated 3 in tumor cell proliferation and survival
[12,22,23]. In addition, ROS influences the DNA damage response and
repair systems through the phosphorylation of ataxia-telangiectasia
mutated protein kinase, p53, and checkpoint kinase 2 [24]. These ob-
servations indicate the effects of ROS-mediated oxidative modification
on the regulation of protein activity in multiple cellular processes. In
this study, we demonstrated that oxidative modification of SERPINA3
accentuates the role of the SERPINA3-HNRNP-K complex on target gene
regulatory DNA.
Serine protease inhibitors (SERPIN, also known as serine-type en-
dopeptidase inhibitors) are a functionally diverse family of proteins
with highly evolutionarily conserved structure from prokaryotes to
placental mammals [25]. Encoded by a member of the SERPIN gene
family, SERPINA3 has been known to be increased in plasma during
proteolysis induced by infection, surgery, and tissue injury based on
several reports dissecting the protein interactome in which SERPINA3
participates [26–30]. In some prokaryotes, reduction–oxidation reac-
tions stabilize SERPIN protein but do not influence its protease in-
hibitory mechanism, suggesting another role of SERPINA3 than as a
serine protease inhibitor [31]. Our current findings demonstrate the
role of SERPINA3 as a novel transcriptional regulator of HCC progres-
sion, irrespective of the conventional role of SERPINA3 as a protease
inhibitor.
Telomeres often form structures, such as T-loop, to protect it from
DNA damage and to regulate telomere length [32]. One of the shelterin
proteins, POT1 is an evolutionarily conserved telomere-binding protein
that is essential in T-loop structure and telomere maintenance [33].
POT1 reportedly modulates telomere length by binding to a 3′ single-
strand overhang telomeric DNA [34,35]. Importantly, its deficiency
causes telomere loss and damage, genomic instability, and cell death
[32]. Similarly, tumor cells overexpressing POT1 display telomere
elongation, while inhibition of POT1 decreases telomere length
[34,35]. Several papers have reported the positive association of POT1
expression and tumorigenesis in human cancers [36,37]. Here, we
showed that POT1 transcription elicited by the SERPINA3-HNRNP-K
complex induced telomere elongation. We also showed that the SER-
PINA3-HNRNP-K complex increased UHRF1 and HIST2H2BE tran-
scriptional levels. UHRF1 functions as a regulator of DNA methylation
and its overexpression drives HCC progression [38]. HIST2H2BE is a
replication-independent histone variant [39] and to our knowledge,
until now, there has been no functional study on HCC-associated
HIST2H2BE. Our data and prior data from the TCGA [40] and GENT
[41] databases show that HCC tumors have high mRNA levels of POT1,
UHRF1, and HIST2H2BE compared with non-tumors. Moreover, we
observed enhanced cell growth, EMT-promoting gene expression, mi-
gration, and invasion through UHRF1 and HIST2H2BE. Collectively,
these results suggest that HNRNP-K increases POT1, UHRF1, and
HIST2H2BE transcription via the ROS-mediated interaction between
SERPINA3 and HNRNP-K in malignant HCC. SERPINA3 mRNA levels
were reported to be lower in HCC tumors compared with non-tumors
[42]. We also observed lower SERPINA3 mRNA levels in HCC cells with
long telomeres relative to those with short telomeres. Notably, HCC
tumors and HCC cells with long telomeres displayed higher SERPINA3
protein levels, suggesting that SERPINA3 activity is determined by the
level of SERPINA3 protein, rather than by the SERPINA3 transcription
level. These results suggest that SERPINA3 protein oxidation induced
by ROS contributes to liver malignancy.
In conclusion, we screened for genes that were essential for telo-
mere maintenance, cell migration and invasion, and cell proliferation in
HCC, and identified the novel function of the SERPINA3-HNRNP-K
complex as the elevated ROS-promoted transcriptional regulator. Thus,
the inhibition of interaction between SERPINA3 and HNRNP-K possibly
via the use of a non-toxic reductant that prevent the oxidation of
SERPINA3 or a specific inhibitor of SERPINA3-HNRNP-K interaction
could block HCC survival and proliferation.
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